ABSI Absci Corp

ABSI financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1672688 Exchange: Nasdaq SIC: 8731 (Services-Commercial Physical & Biological Research) Latest filing: 10-Q filed Aug 11, 2026 Data checked: Oct 21, 2026
Showing 3 of 6 annual and 0 of 24 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity Type
Operating
Public Float
$303.80M (Jun 2025)
Industry (SIC)
8731 Services-Commercial Physical & Biological Research
Fiscal Year End
December (1231)
Phone
(360) 949-1041
EIN
853383487
Headquarters
VANCOUVER, WA, 98683
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: AbSci, LLC (2016–2019)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$1.56M
Net Income
$-121.08M
Total Assets
$268.92M
Total Equity
$246.13M
Total Debt
-
Free Cash Flow
-
Ratios
Operating Margin
-8084.5%
Net Margin
-7756.4%
Return on Equity
-49.2%
Return on Assets
-45%
Current Ratio
10.63x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Absci Corp generated $2.80M of revenue in fiscal 2025, with net loss of $115.18M and an operating cash outflow of $92.92M. The $2.80M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 38.2% below fiscal 2024 revenue of $4.53M, marking a top-line contraction. Diluted earnings per share were -$0.84, translating the period’s attributable earnings into the amount reported for each diluted share. Diluted shares averaged 136.78M; this is the reported share base over which the company’s diluted per-share earnings were spread. Compared with 110.24M diluted shares in fiscal 2024, the current 136.78M base was 24.1% higher. Total assets stood at $216.30M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 0.01x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

The company recorded an operating loss of $120.32M after the reported operating expense base. After all below-operating-line items, the company recorded a net loss of $115.18M for the fiscal year. Negative EBITDA totaled $108.58M, confirming that the earnings deficit remained before depreciation and amortization. The company reported a pretax loss of $115.11M, before the effect of income taxes. Income tax expense totaled $69.00K, providing the reported tax component that separates pretax and after-tax earnings. The loss-to-equity relationship was 60.8%, placing the bottom-line deficit against shareholder capital. The net loss equaled 53.3% of period-end assets, showing the deficit relative to the asset base. The net loss widened to $115.18M from $103.11M in fiscal 2024.

Liquidity and Capital Structure

At period end, the $216.30M asset base was financed through $26.85M of liabilities and $189.45M of equity. At period end, current assets of $149.57M compared with current liabilities of $22.77M, defining the company’s short-term resource position. At 6.57x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $20.02M in cash and equivalents, a narrower liquidity measure than total current assets. The cash balance equaled 88.0% of current liabilities, showing how much near-term coverage came from cash alone. Book equity represented 87.6% of total assets, quantifying the balance-sheet share supported by shareholder capital. Liabilities represented 12.4% of total assets, quantifying the liability-funded share of the company’s resource base. The cash-to-assets relationship was 9.3%, comparing reported cash and equivalents with the full positive asset balance. Compared with $213.61M in fiscal 2024, the current asset base moved 1.3% and finished higher. Against $179.13M of equity in fiscal 2024, the current book-equity balance moved 5.8% and ended higher. The reported cash balance changed 51.4% from $41.21M in fiscal 2024, ending lower year over year.

Cash Flow and Earnings Quality

Operating activities used $92.92M of cash, resulting in an operating cash outflow for the year. The company spent $1.11M on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. The company recorded a $94.03M cash deficit after capital spending for the period. The cash deficit after capital spending represented 43.5% of the period-end asset base. Compared with a $72.40M operating cash outflow in fiscal 2024, the current outflow increased to $92.92M.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Absci Corp
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $2.80M $4.53M $5.72M
OPERATING EXPENSES
R&D Expense $81.42M $63.86M $48.07M
SG&A Expense $35.06M $36.17M $37.83M
Operating Income $-120.32M $-108.89M $-115.52M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $1.01M
Other Income/Expense $5.41M $6.42M $6.06M
Pretax Income $-115.11M $-103.04M $-110.47M
Income Tax $69.00K $70.00K $100.00K
Net Income $-115.18M $-103.11M $-110.57M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-0.84 $-0.94 $-1.20
Diluted Shares 136.78M 110.24M 92.03M
EBITDA $-108.58M $-95.50M $-101.52M
Depreciation & Amortization $11.74M $13.39M $14.00M
Balance Sheet
ASSETS
Cash & Equivalents $20.03M $41.21M $72.36M
Short-term Investments $124.27M $71.21M -
Accounts Receivable - $0 $2.19M
Other Current Assets $5.28M $5.46M $4.54M
Current Assets $149.57M $133.83M $120.58M
PP&E (Net) $20.86M $29.17M $41.33M
Goodwill - - $0
Intangible Assets $41.51M $44.88M $48.25M
Other Noncurrent Assets $383.00K $705.00K $1.54M
Noncurrent Assets $66.72M $79.78M $96.72M
Total Assets $216.30M $213.61M $217.30M
LIABILITIES
Accounts Payable $2.76M $3.53M $1.50M
Current Liabilities $22.77M $28.66M $29.56M
Long-term Debt - $3.99M $7.92M
Other Noncurrent Liabilities $1.02M $133.00K $33.00K
Noncurrent Liabilities $4.08M $5.82M $11.56M
Total Liabilities $26.85M $34.48M $41.12M
EQUITY
Common Stock $15.00K $12.00K $9.00K
Additional Paid-in Capital $813.63M $688.73M $582.70M
Retained Earnings $-624.78M $-509.60M $-406.50M
Accumulated OCI $591.00K $-4.00K $-37.00K
Total Equity $189.45M $179.13M $176.18M
Total Liabilities & Equity $216.30M $213.61M $217.30M
SUPPLEMENTAL
Shares Outstanding - 115.36M 93.09M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-92.93M $-72.40M $-64.64M
Capital Expenditures $1.11M $404.00K $860.00K
Cash from Investing $-50.16M $-41.58M $81.94M
Cash from Financing $105.95M $82.53M $-4.48M
Free Cash Flow $-94.03M $-72.81M $-65.50M
Beginning Cash (CFS) $58.21M $89.67M $76.84M
Net Change in Cash $-37.14M $-31.45M $12.83M
Effect of FX on Cash - - -
Calculated Ending Cash $21.08M $58.21M $89.67M
Cash per BS $20.03M $41.21M $72.36M
Cash scope difference (CFS − BS) $1.05M $17.00M $17.31M
Cash per CFS $21.08M $58.21M $89.67M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Absci Corp's annual revenue?

Absci Corp reported $1.56M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Absci Corp profitable?

No. Absci Corp reported $-121.08M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.